StocksFin Logo
Grifols, S.A.
Grifols, S.A. country of incorporation
|
https://www.grifols.com
|
Mr. Raimon Grifols Roura
|
27,584 employees
NASDAQ | Healthcare | Drug Manufacturers—General
Viatris Inc.
Viatris Inc. country of incorporation
|
https://www.viatris.com
|
Mr. Robert J. Coury
|
37,000 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
Q222 reported Jun 30, 2022 Reporting Period
$1.54B 14.1% vs. Q221 Revenues Q222
37.46% -12.8% vs. Q221 Gross Profit Margin
5.86% -42.2% vs. Q221 Net Profit Margin
88.81M -79.6% vs. Q221 Free Cash Flow Q222
$0.13 -34% vs. Q221 EPS Q222
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q222
Q322
1.41%
Q322 reported Nov 7, 2022 Reporting Period
$4.08B -10.1% vs. Q321 Revenues Q322
42.87% 23.6% vs. Q321 Gross Profit Margin
8.69% 26.5% vs. Q321 Net Profit Margin
753.3M -30.6% vs. Q321 Free Cash Flow Q322
$0.29 11.5% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q222
Q322
1.41%
Ratios
As of
Dec 31, 2021
Sep 30, 2022
Quick Ratio
0.92
0.66
Current Ratio
1.59
1.61
Cash Ratio
0.19
0.1
Price to Book
1.11
0.54
Price to Sales
1.37
2.53
Price to Earnings
37.02
7.29